
Ackerman and Bunick review 52-week AMETHYST data for litifilimab in refractory cutaneous lupus and make the case for dermatology-led CLE care.
In this iteration of our Month in Review series, we highlight some of the most notable stories covered in April in the dermatology field.
Every month, the HCPLive editorial team publishes a Month in Review series highlighting some of the most notable news coverage from the month in each medical subfield. Here, we highlight some of our biggest stories in the field of






